Bayer agrees to help CureVac produce coronavirus vaccine

German drug conglomerate Bayer will help CureVac manufacture tens of millions more doses of the biotech's experimental coronavirus vaccine beginning as soon as the end of this year, company executives said in a Monday briefing with the German health minister.